MedPath

A clinical trial to study the effects of Fixed Dose Combination of Salbutamol & Beclometasone Pressurized Inhalation in patients With Stable Persistent Asthma

Phase 3
Completed
Conditions
Health Condition 1: null- Asthma
Registration Number
CTRI/2012/10/003073
Lead Sponsor
Glenmark Pharmaceuticals Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
280
Inclusion Criteria

1. Male or female outpatients aged >=18 to <=70 years inclusive, with stable persistent asthma

2. Clinical diagnosis of asthma for at least 6 months prior to screening and FEV1 >=70 % to <=90% of predicted normal value

3. Patients able to demonstrate at least 12% improvement in FEV1 and 200ml after 30 minutes (±10mins) after inhalation of Salbutamol 400μg

4. Patient willing to perform all study related procedures including the use of study inhalers, Spirometry and peak flow meter and willing to complete the patient diary

Exclusion Criteria

1. COPD as defined by the European Respiratory Society (ERS) â?? Consensus Statement;

2. Patients with more than 10 packs/year of cigarettes history and current smokers

3. Patients with a history of hypersensitivity to salbutamol/beclomethasone and or any other ingredients

4. History of near fatal asthma and/or admission in intensive care unit because of asthma

5. Female subjects who are pregnant, nursing or planning a pregnancy during the study

6. Patient has any uncontrolled systemic disease or patient has had any major surgery within 4 weeks of study start

7. History of alcohol and/or substance abuse within 12 months prior to the Screening Visit

8. Subjects who have participated in another investigational drug or device research study within 30 days of enrollment

9. Subjects who are using any medication or has any disease which in the judgment of the investigator will interfere with the conduct or interpretation of the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath